GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (XTER:1SXP) » Definitions » FCF Margin %

Schott Pharma AG KGaA (XTER:1SXP) FCF Margin % : 1.41% (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Schott Pharma AG KGaA FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Schott Pharma AG KGaA's Free Cash Flow for the three months ended in Dec. 2024 was €3.2 Mil. Schott Pharma AG KGaA's Revenue for the three months ended in Dec. 2024 was €229.8 Mil. Therefore, Schott Pharma AG KGaA's FCF Margin % for the quarter that ended in Dec. 2024 was 1.41%.

As of today, Schott Pharma AG KGaA's current FCF Yield % is 1.52%.

The historical rank and industry rank for Schott Pharma AG KGaA's FCF Margin % or its related term are showing as below:

XTER:1SXP' s FCF Margin % Range Over the Past 10 Years
Min: 0.68   Med: 3.58   Max: 8.36
Current: 4.79

During the past 5 years, the highest FCF Margin % of Schott Pharma AG KGaA was 8.36%. The lowest was 0.68%. And the median was 3.58%.

XTER:1SXP's FCF Margin % is ranked better than
66.1% of 823 companies
in the Medical Devices & Instruments industry
Industry Median: -3.62 vs XTER:1SXP: 4.79

Schott Pharma AG KGaA FCF Margin % Historical Data

The historical data trend for Schott Pharma AG KGaA's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA FCF Margin % Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24
FCF Margin %
3.27 5.18 3.58 0.68 8.36

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.16 -1.20 13.42 4.76 1.41

Competitive Comparison of Schott Pharma AG KGaA's FCF Margin %

For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Schott Pharma AG KGaA's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Schott Pharma AG KGaA's FCF Margin % falls into.


;
;

Schott Pharma AG KGaA FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Schott Pharma AG KGaA's FCF Margin for the fiscal year that ended in Sep. 2024 is calculated as

FCF Margin=Free Cash Flow (A: Sep. 2024 )/Revenue (A: Sep. 2024 )
=80.03/957.091
=8.36 %

Schott Pharma AG KGaA's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=3.247/229.841
=1.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Schott Pharma AG KGaA FCF Margin % Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Schott Pharma AG KGaA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (XTER:1SXP) » Definitions » FCF Margin %
Comparable Companies
XTER:FIE XTER:GXI XTER:AFX ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XSWX:STMN XPAR:DIM BAX COO WST XTER:SRT HOLX SOLV ALGN
Traded in Other Exchanges
1SXPd:UK 1SXP:Austria
Address
Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Website
https://www.schott-pharma.com
Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.
Executives
Dr. Jens Schulte Supervisory Board
Andreas Reisse Board of Directors
Ann-kristin Erkens Supervisory Board
Dr. Almuth Steinkühler Board of Directors
Dr. Wolfgang Wienand Supervisory Board
Peter Goldschmidt Supervisory Board

Schott Pharma AG KGaA Headlines

No Headlines